We found a reduced proportion of BrdU+ cells expressing Prox1 in DG-NR1KO mice at 28 d, but not 7 d, after BrdU injection (Fig
Studies using twice-daily dosing during acute phases show faster initial response compared to once-daily protocols
I am completing the 1st month and already recieved/ordered the 2nd month titration and have lost 12 pounds so far
Truthfully, with the variety of effective FDA-approved prescriptions for things like cognition and anxiety, the odds arent all that in your favor unless Selanks seemingly lower side effect profile is a chief factor informing the decision
The FDA has classified BPC-157 as a Category 2 bulk drug substance, i.e., its use raises significant safety concerns, and the available evidence is insufficient to support its safety
The schedule can vary depending on deficiency severity, nerve symptoms, and treatment response